rogues, been looking at tumor markers. a coincidence it gets mentioned in the AACC anteo categories and we have the Anteo Luninex webinar next month and then check out the following Merck link.
https://www.merckmillipore.com/AU/en/life-science-research/protein-detection-quantification/Immunoassay-Platform-Solutions/milliplex-multiplex-assays-using-luminex/cancer/3Oub.qB.TkcAAAFB_3kRRk_a,nav?ReferrerURL=https://www.google.com/&bd=1
Ann: AnteoTech Developing Multiplex Test for COVID-19, page-477
-
- There are more pages in this discussion • 292 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $54.77M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.2¢ | 2.0¢ | $12.70K | 583.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1191253 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 520012 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |